COViMS (COVID-19 Infections in MS & Related Diseases) is a joint effort of the
National MS Society and the
Consortium of MS Centers to capture information on outcomes of people with MS and other CNS demyelinating diseases (Neuromyelitis Optica, or MOG antibody disease) who have developed COVID-19.
If you have a patient who has highly suspicious or laboratory confirmed COVID19, we ask that you enter those cases into the database. As the purpose is outcomes of COVID19,
Please report only after a minimum of 7 days and sufficient time has passed to observe the disease course through resolution of acute illness or death. View current data.